AMGEN INC 4

Amgen SVP Rachna Khosla sold a net 2,000 Amgen (AMGN) shares and executed an option exercise with a same-day sale of 1,252 shares while maintaining beneficial ownership of 6,404 shares.

On August 11, 2026, Amgen Inc. SVP of Business Development Rachna Khosla sold 2,000 shares of Amgen common stock at an average price of $412.567 per share, for proceeds of roughly $825,000, leaving her with 6,404 shares. On August 13, 2026, she exercised a non-qualified stock option for 1,252 shares at an exercise price of $162.60 per share (approximately $203,000 in option cost), and immediately sold all 1,252 shares at an average price of $416.4256 per share for proceeds of about $521,000, returning her direct holdings to 6,404 shares. The filing notes that some of the shares sold were used to cover the option exercise price and required withholding taxes, and that her holdings include 69 dividend equivalents issued under Amgen’s equity incentive plan.

Filing Facts

CIK

318154

Ticker

AMGN

Form

4

Source Type

fda

Accession

0000318154-26-000137

Alert Tier

8